Zepbound HSA/FSA Eligibility and Submission: Complete 2026 Guide

Is Zepbound HSA/FSA Eligible?

Zepbound is eligible for HSA and FSA reimbursement under IRS Section 213(d), which defines a deductible medical expense as any amount paid for the "diagnosis, cure, mitigation, treatment, or prevention of disease." Because obesity is classified as a disease by the American Medical Association and the FDA approved tirzepatide specifically for chronic weight management, a prescription for Zepbound meets this standard directly. Your plan administrator may require a Letter of Medical Necessity (LMN) as supporting documentation.

The IRS Section 213(d) Standard

The Internal Revenue Service allows HSA and FSA funds to pay for prescription drugs that treat a recognized medical condition. IRS Publication 502 lists "prescription medicines or drugs" as an eligible expense with no category exclusion for weight-loss drugs when the underlying purpose is treating a disease rather than general wellness.

Zepbound received FDA approval on November 8, 2023, for adults with a BMI of 30 or above, or BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia. [1] A second FDA approval followed on June 21, 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity. [2] Both indications are disease treatments, not cosmetic or general wellness interventions.

Why the Prescription Requirement Matters

An HSA or FSA cannot reimburse an over-the-counter drug without a prescription. Zepbound is available by prescription only, so the prescription itself satisfies that gate. What some plan administrators add on top of that requirement is proof of a qualifying diagnosis. Keeping the prescription and your clinical visit note together before you fill will simplify submission considerably.

Plan Administrator Variation

While the IRS standard is consistent, individual FSA administrators (e.g., HealthEquity, WEX, Optum Financial, Inspira) set their own substantiation workflows. Some auto-approve prescription drugs at the pharmacy point of sale; others flag GLP-1 drugs for manual review. Calling your administrator before your first fill takes roughly ten minutes and prevents a rejected claim later.

How to Submit a Zepbound HSA/FSA Claim

Submitting a claim correctly the first time cuts reimbursement time from weeks to days. The process differs slightly depending on whether you pay at the pharmacy or receive Zepbound through a specialty pharmacy or telehealth platform. [3]

Step-by-Step Pharmacy Submission

1. Fill the prescription at your preferred pharmacy.
2. Pay out of pocket with your HSA debit card, FSA debit card, or personal funds.
3. Save the itemized pharmacy receipt. It must show the drug name (tirzepatide or Zepbound), date of service, drug cost, and your name.
4. Log into your benefits portal and upload the receipt. Some administrators also accept the Explanation of Benefits (EOB) from your insurer if insurance was billed first.
5. If the claim is flagged, submit your prescription printout and, if requested, an LMN from your prescriber.

What a Letter of Medical Necessity Should Include

An LMN is a brief clinical note on provider letterhead that states:

• Your name and date of birth
• The diagnosis (e.g., "obesity, ICD-10 E66.01" or "moderate obstructive sleep apnea, ICD-10 G47.33")
• The prescribed medication (Zepbound / tirzepatide) and dose
• The clinical rationale, referencing your BMI and comorbidities
• The expected treatment duration

Most plan administrators accept a single LMN per calendar year. Some accept the prescription label plus a printed clinical summary from your patient portal.

HSA Debit Card vs. Manual Reimbursement

Paying directly with your HSA debit card at the pharmacy is the simplest path. The transaction posts immediately and creates a record in your HSA account. If your FSA uses a debit card, the same logic applies, though your employer's FSA administrator may still require a receipt upload within 30 to 90 days to substantiate the charge. Paying from personal funds and seeking manual reimbursement is also allowed but adds processing time.

How Much Can You Save With an HSA or FSA?

The savings are real and calculable. HSA and FSA contributions are made pre-tax, meaning each dollar you spend on Zepbound through these accounts costs you only 63 to 78 cents in gross income depending on your federal bracket.

Tax-Bracket Math

At the 22% federal bracket, a $1,060 monthly Zepbound prescription costs $827 in effective dollars when paid through an HSA or FSA. At the 37% bracket, the same prescription costs $668. Those figures do not account for state income tax savings in the roughly 43 states that conform to the federal HSA exclusion, which would push effective savings higher still.

Annual contribution limits for 2026 are $4,300 for individual HSA holders and $8,550 for family coverage, per IRS Revenue Procedure guidance. [4] FSA limits are set by employers but cannot exceed $3,300 per IRS rules. Zepbound's annual list price of approximately $12,720 exceeds these limits, so HSA/FSA savings apply to the covered portion only.

Stacking Tax Savings With Lilly's Savings Card

Eli Lilly's Zepbound savings card allows commercially insured patients to pay as little as $550 per month after the card is applied. Uninsured or cash-pay patients may qualify for the $25/month introductory offer through Lilly's direct program (subject to eligibility and program availability at time of fill). [5]

The important question is whether HSA/FSA funds can be used after a manufacturer coupon has already reduced the price. IRS Notice 2019-45 did not address this scenario directly, and plan administrator policies vary. Many administrators allow HSA/FSA payment on the remaining patient-pay amount after the savings card is applied. Confirm this with your specific administrator before assuming stacking is permitted.

Zepbound Coverage and Insurance in 2026

Understanding insurance coverage affects how you deploy HSA and FSA dollars most efficiently. [6]

Commercial Insurance Trends

As of 2025, fewer than 30% of large employer health plans covered GLP-1 drugs for obesity, according to KFF benefit surveys, though coverage for the OSA indication is growing faster because it ties to a more broadly covered condition. When your insurer covers Zepbound, HSA/FSA funds apply to your deductible and copay, which are the most natural use cases.

Medicare and Medicaid

Medicare Part D began covering Zepbound for obesity under the Inflation Reduction Act provisions taking effect in 2026 for select plans, though formulary placement varies by plan. Medicaid coverage is state-dependent. Neither Medicare nor Medicaid enrollees can use manufacturer savings cards, but Medicare beneficiaries with HSAs from prior employer coverage (if contributions stopped at Medicare enrollment) may draw on existing balances. [7]

Prior Authorization Documentation

When pursuing insurance coverage, your prescriber will submit prior authorization documents that include your ICD-10 diagnosis code and BMI. Those same documents serve double duty. Requesting a copy for your own records means you already have the substantiation package ready for an HSA/FSA claim if insurance denies or covers only partially.

How to Get Zepbound Cheaper: A Full Cost-Reduction Toolkit

Tirzepatide's list price is a barrier for many patients, but several cost pathways exist beyond tax-advantaged accounts alone. [8]

Lilly Direct and LillyLink

Eli Lilly launched Zepbound vials (tirzepatide in single-dose vials) through LillyDirect in late 2023 at prices ranging from $399 to $549 per month depending on dose, for self-pay patients without insurance coverage. These vials are FDA-approved and manufactured in the same facilities as the autoinjector pens. Patients order through the Lilly platform and work with a contracted telehealth provider. HSA/FSA funds are accepted on the LillyDirect platform for the patient-pay amount. [9]

Compounded Tirzepatide

The FDA placed tirzepatide on its shortage list in 2023, allowing 503A and 503B compounding pharmacies to produce tirzepatide. The FDA officially removed tirzepatide from the shortage list in May 2025, ending the period during which compounded versions were broadly permissible. [10] As of mid-2025, FDA enforcement discretion guidance applied narrowly, meaning compounded tirzepatide from most pharmacies no longer has the same legal standing it once did. Patients should consult their prescriber about this shift before pursuing compounded versions, and they should be aware that HSA/FSA eligibility for compounded drugs depends on whether the compound is FDA-approved, which compounded tirzepatide is not.

GoodRx and Cash-Pay Pharmacies

GoodRx and similar discount programs offer negotiated cash prices at select pharmacies. These prices are not combinable with insurance but can be paid with HSA/FSA funds. As of early 2026, GoodRx cash prices for tirzepatide 2.5 mg (4 pens) range from approximately $900, $1,050 depending on pharmacy and geography, which may or may not be lower than your insurance copay. Run both numbers before filling.

Employer Benefit Advocacy

A small but growing number of employers are adding GLP-1 coverage through specialty carve-out benefits via vendors such as Hinge Health or Omada Health. These programs often include clinical oversight that improves both access and outcomes. Contacting your HR benefits team and citing the cardiovascular outcome data from SURMOUNT-OSA may strengthen a case for coverage. [11]

Clinical Efficacy Data Supporting Medical Necessity

When writing an LMN or appealing an insurance denial, citing the clinical trial record strengthens the case for Zepbound's medical necessity designation. [12]

SURMOUNT-1 Weight Loss Outcomes

SURMOUNT-1 (N=2,539) demonstrated that tirzepatide 15 mg produced a mean 20.9% reduction in body weight at 72 weeks versus 3.1% with placebo (P<0.001). [13] Participants achieved a mean weight loss of 22.5 kg on the highest dose. These are not cosmetic results. They represent clinically meaningful reductions in cardiovascular risk factors and metabolic burden.

SURMOUNT-OSA Sleep Apnea Evidence

The SURMOUNT-OSA trials (two parallel trials, each approximately N=230) showed that tirzepatide reduced the apnea-hypopnea index (AHI) by 27.4 events per hour compared with 4.8 events per hour on placebo in patients who did not use positive airway pressure therapy. [14] This reduction corresponds to a shift from severe to mild OSA for many participants. The FDA cited these trials in the June 2024 approval for obstructive sleep apnea, providing a second documented medical indication.

Endocrine Society Guidelines

The Endocrine Society's 2023 Clinical Practice Guideline on obesity pharmacotherapy states: "We recommend anti-obesity medications as an adjunct to lifestyle modification for adults with obesity (BMI >30 kg/m2) or for adults who are overweight (BMI 27 to 29.9 kg/m2) with at least one weight-related comorbidity." [15] Quoting this guideline language in an LMN or appeal letter anchors the prescription firmly within standard-of-care practice.

Documentation Checklist Before You Submit

Gathering these items before your first HSA/FSA submission prevents delays.

Required Documents

• Itemized pharmacy receipt showing drug name, date, and amount
• Copy of the prescription (from patient portal or pharmacy printout)
• ICD-10 diagnosis code from your most recent clinical note (E66.01 for morbid obesity due to excess calories; G47.33 for obstructive sleep apnea; E11.x for type 2 diabetes if that is the weight-related comorbidity)

Conditionally Required Documents

• Letter of Medical Necessity, if your administrator flags the claim
• Explanation of Benefits from your insurer, if Zepbound was billed to insurance first
• Proof of eligibility for your HSA/FSA plan year

What to Do if a Claim Is Denied

Call your administrator the same day. Ask for the specific denial reason in writing. Most denials for GLP-1 drugs fall into two categories: (a) the administrator codes the drug as a "weight-loss" item rather than a "prescription drug," or (b) the receipt lacks the required substantiation fields. Resubmitting with an LMN resolves category-a denials in the majority of cases. A clean itemized receipt resolves category-b denials.

HSA vs. FSA: Which Account Is Better for Zepbound?

Both account types cover Zepbound, but they have meaningfully different rules that affect how you plan your spending. [16]

HSA Advantages for Long-Term Therapy

HSA funds roll over indefinitely. Zepbound is typically a long-term or indefinite therapy, SURMOUNT-4 (N=670) showed that patients who discontinued tirzepatide after 36 weeks regained approximately two-thirds of their lost weight within one year. [17] Because treatment is ongoing, an HSA's carryover feature means unused balances accumulate and remain available without a "use it or lose it" penalty.

HSA accounts also allow investment of funds above a threshold (typically $1,000, $2,000 depending on custodian). If your insurance covers most of your Zepbound cost and you need HSA funds only for the copay, investing the surplus and drawing it down over time is a legitimate tax strategy.

FSA Considerations

FSAs offer a "uniform coverage rule" that makes your full annual election available on January 1. If you start Zepbound in January and need $3,300 upfront, an FSA covers that even before your payroll contributions fund the account. The tradeoff is the use-it-or-lose-it rule. Plan your annual FSA election based on realistic cost estimates for the full year, accounting for your savings card and insurance coverage.

A Dependent Care FSA does not cover Zepbound. Only a Healthcare FSA or Limited Purpose FSA (used with an HSA) applies. Limited Purpose FSAs cover dental and vision only, not prescription drugs, so do not confuse the two.

Common Mistakes That Lead to Denied Claims

Knowing the failure modes in advance is the most efficient way to avoid them.

Using a general wellness framing. If your LMN says "patient wants to lose weight for better health," some administrators will code this as cosmetic. The language should specify the ICD-10 diagnosis and the clinical threshold crossed (e.g., "BMI 34.2 with hypertension, ICD-10 E66.01 and I10").

Submitting a credit card receipt instead of an itemized receipt. A credit card statement showing a pharmacy charge does not satisfy substantiation requirements. The itemized receipt must come from the pharmacy itself.

Assuming plan-year timing does not matter. HSA/FSA claims must correspond to the plan year in which the expense was incurred. A prescription filled December 28, 2025, cannot be reimbursed from a 2026 FSA election.

Forgetting to check HSA-disqualifying coverage. You cannot contribute to an HSA if you are enrolled in a non-HDHP health plan, Medicare, or Tricare. Verify your eligibility before the contribution deadline to avoid IRS penalties on ineligible contributions.